Concepedia

Yoshihide Miyake

YM

Statistics

Publications

4

Citations

96

H-Index

4

Active since

2015

Affiliations

Kaken Pharmaceutical (Japan)(Current)

Yoshihide Miyake is an author at Kaken Pharmaceutical (Japan) specializing in gastroenterology, immunology, and inflammation.

ORCID

Top concepts

Publications per year

2015–2024

4

Publications

4

KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration

Yusuke Watanabe, Masahiro Amakawa, Yoshihide Miyake et al. · European Journal of Pharmacology · 2015 · 39 citations · Full text

, , +23

Establishment of a system to evaluate the therapeutic effect and the dynamics of an investigational drug on ulcerative colitis using human colonic organoids

Ryu Nishimura, Tomoaki Shirasaki, Kiichiro Tsuchiya et al. · Journal of Gastroenterology · 2019 · 27 citations

, , +7

Oral administration of EP4-selective agonist KAG-308 suppresses mouse knee osteoarthritis development through reduction of chondrocyte hypertrophy and TNF secretion

Yasutaka Murahashi, Fumiko Yano, Ryota Chijimatsu et al. · Scientific Reports · 2019 · 19 citations · Full text

A Bispecific, Tetravalent Antibody Targeting Inflammatory and Pruritogenic Pathways in Atopic Dermatitis

Julia Tietz, Tea Gunde, Stefan Warmuth et al. · JID Innovations · 2024 · 11 citations · Full text

1–4 of 4